Episode 3: Ongoing Research for New HAE treatments. HAE Speaks
-
- Sin fines de lucro
Tony Castaldo, CEO of the HAE Association provides an information packed update on the new HAE treatments that are being developed by 9 companies. Tune in to this podcast for the latest exciting details about this vitally important HAE research.
Here is a list of companies and their websites listed in order as they are discussed in the podcast.
BioCryst: www.biocryst.com
Kalvista: www.kalvista.com
Phavaris: pharvaris.com
Attune Pharmaceuticals: attunepharma.com
CSL Behring: www.cslbehring.com
BioMarin: www.biomarin.com
RegenxBio: www.regenxbio.com
Intellia Therapeutics: www.intelliatx.com
Ionis Pharmaceuticals: www.ionispharma.com
Tony Castaldo, CEO of the HAE Association provides an information packed update on the new HAE treatments that are being developed by 9 companies. Tune in to this podcast for the latest exciting details about this vitally important HAE research.
Here is a list of companies and their websites listed in order as they are discussed in the podcast.
BioCryst: www.biocryst.com
Kalvista: www.kalvista.com
Phavaris: pharvaris.com
Attune Pharmaceuticals: attunepharma.com
CSL Behring: www.cslbehring.com
BioMarin: www.biomarin.com
RegenxBio: www.regenxbio.com
Intellia Therapeutics: www.intelliatx.com
Ionis Pharmaceuticals: www.ionispharma.com
13 min